Publications by authors named "Michael A Posternak"

Claim this Profile
R
Response rates to fluoxetine in subjects who initially show no improvement.
Michael A Posternak, Lee Baer, Andrew A Nierenberg, Maurizio Fava

J Clin Psychiatry· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous initiation (coinitiation) of pharmacotherapy with triiodothyronine and a selective serotonin reuptake inhibitor for major depressive disorder: a quantitative synthesis of double-blind studies.
George I Papakostas, Rena Cooper-Kazaz, Bente C Appelhof, Michael A Posternak, Daniel P Johnson

Int Clin Psychopharmacol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remission in depressed outpatients: more than just symptom resolution?
Mark Zimmerman, Joseph B McGlinchey, Michael A Posternak, Michael Friedman, Daniela Boerescu

J Psychiatr Res· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A clinically useful depression outcome scale.
Mark Zimmerman, Iwona Chelminski, Joseph B McGlinchey, Michael A Posternak

Compr Psychiatry· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneity among depressed outpatients considered to be in remission.
Mark Zimmerman, Michael A Posternak, Iwona Chelminski

Compr Psychiatry· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic effect of follow-up assessments on antidepressant and placebo response rates in antidepressant efficacy trials: meta-analysis.
Michael A Posternak, Mark Zimmerman

Br J Psychiatry· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of study design on the results of continuation studies of antidepressants.
Mark Zimmerman, Michael A Posternak, Camilo J Ruggero

J Clin Psychopharmacol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validity of a self-report depression symptom scale for identifying remission in depressed outpatients.
Mark Zimmerman, Michael A Posternak, Joseph McGlinchey, Michael Friedman, Naureen Attiullah

Compr Psychiatry· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of gender, age and depressed state on patients' perspectives of remission.
Joseph B McGlinchey, Mark Zimmerman, Michael A Posternak, Michael Friedman, Naureen Attiullah

J Affect Disord· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing brief scales for use in clinical practice: the reliability and validity of single-item self-report measures of depression symptom severity, psychosocial impairment due to depression, and quality of life.
Mark Zimmerman, Camilo J Ruggero, Iwona Chelminski, Diane Young, Michael A Posternak

J Clin Psychiatry· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The naturalistic course of unipolar major depression in the absence of somatic therapy.
Michael A Posternak, David A Solomon, Andrew C Leon, Timothy I Mueller, M Tracie Shea

J Nerv Ment Dis· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A description of next-step switching versus augmentation practices for outpatients with treatment-resistant major depressive disorder enrolled in an academic specialty clinic.
George I Papakostas, Timothy J Petersen, Cassandra Green, Dan V Iosifescu, Albert S Yeung, Michael A Posternak

Ann Clin Psychiatry· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of insight into delusional beliefs in schizophrenia using the Brown Assessment of Beliefs Scale.
Gary B Kaplan, Katharine A Phillips, Amie Vaccaro, Jane L Eisen, Michael A Posternak

Schizophr Res· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discordance between self-reported symptom severity and psychosocial functioning ratings in depressed outpatients: implications for how remission from depression should be defined.
Mark Zimmerman, Joseph B McGlinchey, Michael A Posternak, Michael Friedman, Daniela Boerescu

Psychiatry Res· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardized clinical outcome rating scale for depression for use in clinical practice.
Mark Zimmerman, Michael A Posternak, Iwona Chelminski, Michael Friedman

Depress Anxiety· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How should remission from depression be defined? The depressed patient's perspective.
Mark Zimmerman, Joseph B McGlinchey, Michael A Posternak, Michael Friedman, Naureen Attiullah

Am J Psychiatry· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and features of intermittent explosive disorder in a clinical setting.
Emil F Coccaro, Michael A Posternak, Mark Zimmerman

J Clin Psychiatry· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences between minimally depressed patients who do and do not consider themselves to be in remission.
Mark Zimmerman, Joseph B McGlinchey, Michael A Posternak, Michael Friedman, Daniela Boerescu

J Clin Psychiatry· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Empirical testing of two models for staging antidepressant treatment resistance.
Timothy Petersen, George I Papakostas, Michael A Posternak, Alexis Kant, Wendy M Guyker

J Clin Psychopharmacol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual reuptake inhibitors incur lower rates of tachyphylaxis than selective serotonin reuptake inhibitors: a retrospective study.
Michael A Posternak, Mark Zimmerman

J Clin Psychiatry· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Why isn't bupropion the most frequently prescribed antidepressant?
Mark Zimmerman, Michael A Posternak, Naureen Attiullah, Michael Friedman, Robert J Boland

J Clin Psychiatry· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is it time to replace the Hamilton Depression Rating Scale as the primary outcome measure in treatment studies of depression?
Mark Zimmerman, Michael A Posternak, Iwona Chelminski

J Clin Psychopharmacol· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is the cutoff to define remission on the Hamilton Rating Scale for Depression too high?
Mark Zimmerman, Michael A Posternak, Iwona Chelminski

J Nerv Ment Dis· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tachyphylaxis in unipolar major depressive disorder.
David A Solomon, Andrew C Leon, Timothy I Mueller, William Coryell, Jedediah J Teres, Michael A Posternak

J Clin Psychiatry· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis